Effects of the N-terminal sequence of ACE on the properties of its C- domain

Hypertension

Volumn 36, Issue 1, 2000, Pages 116-121

  Marcic, Branislav ^a   Deddish, Peter A ^a   Jackman, Herbert L ^a   Erdös, Ervin G ^a,b   Tan, Fulong ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Angiotensin; Angiotensin converting enzyme inhibitors; Arachidonic acid; Bradykinin; Calcium; Receptors, bradykinin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CALCIUM MOBILIZATION; CHO CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

EID: 0033865185     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.36.1.116-a     Document Type: Article

References (33)

1. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A. 1988; 85:9386-9390.
2. Jaspard E, Wei L, Alhenc-Gelas F. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II): studies with bradykinin and other natural peptides. J Biol Chem. 1993;268:9496-9503.
3. Kumar RS, Kusari J, Roy SN, Soffer RL, Sen GC. Structure of testicular angiotensin-converting enzyme: a segmental mosaic enzyme. J Biol Chem. 1989;264:16754-16758.
4. Corvol P, Williams TA. Peptidyl-dipeptidase A/angiotensin I-converting enzyme. In: Barrett AJ, Rawlings ND, Woessner JF, eds. Handbook of Proteolytic Enzymes. San Diego, Calif: Academic Press; 1998: 1066-1076.
5. Erdös EG, Deddish PA, Marcic BM. Potentiation of bradykinin actions by ACE inhibitors. Trends Endocrinol Metab. 1999;10:223-229.
6. Skidgel RA, Erdös EG. Novel activity of human angiotensin I converting enzyme: release of the N- and C-terminal tripeptides from the luteinizing hormone-releasing hormone. Proc Natl Acad Sci U S A. 1985;82: 1025-1029.
7. Ehlers MRW, Riordan JF. Angiotensin converting enzyme; zinc-and inhibitor-binding stoichiometries of the somatic and testis isozymes. Biochemistry. 1991;30:7118-7126.
8. Skidgel RA, Erdös EG. Biochemistry of angiotensin converting enzyme. In: Robertson JIS, Nicholls MG, eds. The Renin-Angiotensin System. Vol. 1. London, England: Gower Medical Publishers; 1993:10.1-10.10.
9. Deddish PA, Jackman HL, Skidgel RA, Erdös EG. Differences in the hydrolysis of enkephalin congeners by the two domains of angiotensin converting enzyme. Biochem Pharmacol. 1997;53:1459-1463.
10. Deddish PA, Marcic B, Jackman HL, Wang H-Z, Skidgel RA, Erdös EG. N-domain specific substrates and C-domain inhibitors of angiotensin converting enzyme: angiotensin-(1-7) and keto-ACE. Hypertension. 1998;31:912-917.
11. Azizi M, Rousseau A, Ezan E, Guyene T-T, Michelet S, Grognet J-M, Lenfant M, Corvol P, Menard J. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest. 1996;97:839-844.
12. Rousseau A, Michaud A, Chauvet M-T, Lenfant M, Corvol P. The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active sites of human angiotensin-converting enzyme. J Biol Chem. 1995;270:3656-3661.
13. Ward PE, Sheridan MA, Hammon KJ, Erdös EG. Angiotensin I converting enzyme (kininase II) of the brush border of human and swine intestine. Biochem Pharmacot. 1980;29:1525-1529.
14. Deddish PA, Wang J, Michel B, Morris PW, Davidson NO, Skidgel RA, Erdös EG. Naturally occurring active N-domain of human angiotensin I converting enzyme. Proc Natl Acad Sci U S A. 1994;91:7807-7811.
15. Erdös EG, Gafford JT. Human converting enzyme. Clin Exp Hypertens 1983;A5:1251-1262.
16. Minshall RD, Tan F, Nakamura F, Rabito SF, Becker RP, Marcic B, Erdös EG. Potentiation of the actions of bradykinin by angiotensin I converting enzyme (ACE) inhibitors: the role of expressed human bradykinin B2 receptors and ACE in CHO cells. Circ Res. 1997;81:848-856.
17. 2 receptor. Hypertension. 1999;33:835-843.
18. 2+ response in a subclone of PC-12 cells by single cell flow cytometry: inhibition of the response by bradykinin. J Biol Chem. 1991;266:11738-11745.
19. Roberts RA. Bradykinin receptors: characterization, distribution and mechanisms of signal transduction. Prog Growth Factor Res. 1989;1: 237-252.
20. Deddish PA, Wang L-X, Jackman HL, Michel B, Wang J, Skidgel RA, Erdös EG. Single-domain angiotensin converting enzyme (kininase II): characterization and properties. J Pharmacol Exp Ther. 1996;279: 1582-1589.
21. Sturrock ED, Danilov SM, Riordan JF. Limited proteolysis of human kidney angiotensin-converting enzyme and generation of catalytically active N- and C-terminal domains. Biochem Biophys Res Commun. 1997; 236:16-19.
22. Williams TA, Danilov S, Alhenc-Gelas F, Soubrier F. A study of chimeras constructed with the two domains of angiotensin I-converting enzyme. Biochem Pharmacol. 1996;51:11-14.
23. q family couple the bradykinin receptor to the release of endothelium-derived relaxing factor. J Clin Invest. 1993;92:2168-2172.
24. Igic R, Nakajima T, Yeh HSJ, Sorrells K, Erdös EG. Kininases. In: Acheson GH, ed. Symposium on Kinin Peptides: Proceedings of the Fifth International Congress on Pharmacology. Vol. 5. Basel, Switzerland: Karger; 1973:307-319.
25. Erdös EG. Angiotensin I converting enzyme. (Brief review.). Circ Res. 1975;36:247-255.
26. Wei L, Alhenc-Gelas F, Soubrier F, Michaud A, Corvol P, Clauser E. Expression and characterization of recombinant human angiotensin I-converting enzyme: evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. J Biol Chem. 1991;266:5540-5546.
27. Dorer FE, Kahn JR, Lentz KE, Levine M, Skeggs LT. Kinetic properties of pulmonary angiotensin-converting enzyme: hydrolysis of hippurylglycylglycine. Biochim Biophys Acta. 1976;429:220-228.
28. Bünning P, Riordan JF. Sulfate potentiation of the chloride activation of angiotensin converting enzyme. Biochemistry. 1987;26:3374-3377.
29. Marcic BM, Deddish PA, Skidgel RA, Erdös EG, Minshall RD, Tan F. Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors. J Biol Chem. 2000;275:16110-16118.
30. Carretero OA, Scicli AG. The kallikrein-kinin system as a regulator of cardiovascular and renal function. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press Publishers; 1995:983-999.
31. Margolius HS. Kallikreins and kinins: some unanswered questions about system characteristics and roles in human disease. Hypertension. 1995; 26:221-229.
32. 1 MF-2 smooth muscle cells. J Biol Chem. 1997;272:17858-17866.
33. 2 kinin receptor within the plasma membrane of native endothelial cells. Circulation. 1999;99:2034-2040.